This review examines strategies for the prevention and management of obesity, hypertension, type 2 diabetes mellitus and dyslipidaemia, conditions that are increasing in Singapore, as components of individualised health plans in 'Healthier SG' and beyond. We describe cardiometabolic disease prevention and management initiatives in Changi General Hospital (CGH), including collaborations with SingHealth Polyclinics, Active SG, Exercise is Medicine Singapore and community partners in the Eastern Community Health Outreach programme, and highlight advances in curable hypertension (e.g., primary hyperaldosteronism) and novel cardiovascular risk markers such as lipoprotein(a). We also outline technology-based interventions, notably the CGH Health Management Unit, which demonstrate the utility and convenience of telemedicine, and digital therapeutics in the form of apps that have been shown to improve treatment adherence and clinical outcomes. Individual empowerment, in partnership with community and healthcare providers and supported by research and innovation of care delivery, is key to building a healthier and stronger nation.
Humans ; Singapore ; Diabetes Mellitus, Type 2/therapy* ; Hypertension/therapy* ; Obesity/therapy* ; Dyslipidemias/therapy* ; Telemedicine ; Cardiovascular Diseases/prevention & control* ; Exercise ; Metabolic Diseases/prevention & control*

Female ; Humans ; Hypertension ; diagnosis ; therapy ; Male

A patient with red-green colour blindness came to the polyclinic for a medical examination for the purpose of applying for a vocational driving license. He had been driving a private vehicle for years. As he could not read all the plates in the Ishihara, the attending doctor decided not to certify him fit, but referred him to an ophthalmologist. This upset the patient. A review of the guidelines suggests that for colour-blind patients, the Ishihara should not be the standard to assess a patient’s fitness to drive. We propose a simple colour chart that is more practical for this purpose.